Eversept Partners »

Eyepoint Pharmaceuticals shares owned by Eversept Partners

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.3M 298k 14.30

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Encompass Health Corp (EHC)
Ensign (ENSG)
Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Natera (NTRA)
Travere Therapeutics (TVTX)
Caretrust Reit (CTRE)
Hca Holdings (HCA)
Vaxcyte (PCVX)

View all positions for Eversept Partners

Top funds holding Eyepoint Pharmaceuticals

Suvretta Capital Management
BlackRock
Cormorant Asset Management
Federated Investors
Adage Capital Partners GP
Franklin Resources
Commodore Capital
Jupiter Topco
Vanguard Capital Management
Henderson Group
Paradigm Biocapital Advisors
Citadel Advisors
State Street Corporation
Geode Capital Management
Standard Life Aberdeen

View all funds holding Eyepoint Pharmaceuticals